Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army

Journal of Korean Medical Science

Volumn 20, Issue 5, 2005, Pages 707-712

  Yeom, Joon Sup ^a   Ryu, Seung Ho ^a   Oh, Sejoong ^b   Choi, Dong Hyun ^c   Song, Kyoung Jun ^d   Oh, Young Ha ^e   Lee, Jae Hyun ^f   Kim, Young A ^f   Ahn, Sun Young ^f   Yang, Hwa Young ^f   Cha, Je Eun ^f   Park, Jae Won ^f  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Daegu Park Hospital   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d Seoul National University   (South Korea)

^e Hanyang University   (South Korea)

^f Gachon University College of Medicine   (South Korea)

Author keywords

Chemoprevention; Chloroquine; Korea; Malaria; Primaquine; Vivax

Indexed keywords

EID: 24944463987     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.5.707     Document Type: Article

References (23)

1. Galinski MR, Barnwell JW. Plasmodium vivax: merozoites invasion of reticulocytes and considerations for malaria vaccine development. Parasitol Today 1996; 12: 20-9.
2. Paik YH, Ree HI, Shim JC. Malaria in Korea. Jpn J Exp Med 1988; 58: 55-6.
3. Ree HI. Unstable vivax malaria in Korea. Korean J Parasitol 2000; 38: 119-38.
4. World Health Organisation. Synopsis of the world malaria situation in 1979. Wkly Epidemiol Rec 1981; 56: 145-9.
5. Hankey DD, Jones R Jr, Coatney GR, Alving AS, Coker WG, Garrison PL, Donovan WN. Korean vivax malaria. I. Natural history and response to chloroquine. Am J Trop Med Hyg 1953; 2: 958-69.
6. Coatney GR, Alving AS, Jones R Jr, Hankey DD, Robinson DH, Garrison PL, Coker WG, Donovan WN, Di Lorenzo A, Marx RL, Simmons IH. Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg 1953; 2: 985-8.
7. Jones R, Jackson LS, Di Lorenzo A, Marx RL, Levy BL, Kenny EC, Gilbert M, Johnston MN, Alving AS. Korean vivax malaria. III. Curative effect and toxicity of primaquine in doses from 10 to 30 mg daily. Am J Trop Med Hyg 1953; 2: 977-82.
8. Lee JS, Lee WJ, Cho SH, Ree HI. Outbreak of vivax malaria in areas adjacent to the demilitarized zone, South Korea, 1998. Am J Trop Med Hyg 2002; 66: 13-7.
9. Soh CT, Lee KT, Im KI, Min DY, Ahn MH, Kim JJ, Yong TS. Current status of malaria in Korea. Yonsei Rep Trop Med 1985; 16: 11-8.
10. Feighner BH, Park SI, Novakoski WL, Kelsey LL, Strickman D. Reemergence of Plasmodium vivax malaria in the Republic of Korea. Emerg Infect Dis 1998; 4: 295-7.
11. National Institute of Health. Communicable Diseases Monthly Report, Korea. (in Korean). Seoul: Korean National Institute of Health, 1995-2002.
12. Park JW, Klein TA, Lee HC, Pacha LA, Ryu SH, Yeom JS, Moon SH, Kim TS, Chai JY, Oh MD, Choe KW. Vivax malaria: a continuing health threat to the Republic of Korea. Am J Trop Med Hyg 2003; 69: 159-67.
13. Ryu SH, Lee WJ, Kim YA, Chai JY, Park JW. Status of vivax malaria in the Republic of Korea in 2001. Korean J Infect Dis 2002; 34: 267-75.
14. Yeom JS, Lee WJ, Ryu SH, Kim TS, Kim YA, Ahn SY, Yang HY, Park JW. Status of vivax malaria in the Republic of Korea in 2002. Infect Chemother 2003; 35: 385-92.
15. Shute PG, Lupascu G, Branzei P, Maryon M, Constantinescu P, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Gamham PC. A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period. Trans R Soc Trop Med Hyg 1977; 70: 474-81.
16. Ree HI. Can malaria be endemic in South Korea? Korean J Infect Dis 1998; 30: 397-400.
17. Gilles HM, Warrell DA. The Anopheles Vector. In: Gilles HM, Warrell DA. Bruce-Chwatt's Essential Malariology. 3rd ed. Boston: Edward Arnold Press; 1993; 127-31.
18. Centers for Disease Control and Prevention. Health information for international travel: 2003-2004. Atlanta: US Department of Health and Human Sevices, 2003.
19. Committee to Advise on Tropical Medicine and Travel (CATMAT), Laboratory for Disease Control. Canadian recommendations for the prevention and treatment of malaria among international travelers. Can Commun Dis Rep 2000; 26 (Suppl 2): 1-42.
20. Kain KC, Shanks GD, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. Clin Infect Dis 2001; 33: 226-34.
21. Shanks GD, Kain KC, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future. Clin Infect Dis 2001; 33: 381-5.
22. WHO. International travel and health: vaccination requirements and health advice 2000. Geneva: World Health Organization, 2000.
23. Touze JE, Paule P, Baudon D, Boutin JP. Malaria prophylaxis in the French Armed Forces: evolution of concepts. Med Trop 2001; 61: 79-82.